UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005859 |
|---|---|
| Receipt number | R000006925 |
| Scientific Title | Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide Combined with IFA and IFN-alpha for Patients with Urothelial Cancer (Phase I clinical study) |
| Date of disclosure of the study information | 2011/06/28 |
| Last modified on | 2014/03/03 08:40:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/06/28 00:37:25 | ||
| 2 | Update | 2011/06/28 00:42:38 | Date of disclosure of the study information |
|
| 3 | Update | 2014/03/03 08:37:01 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications Results |
|
| 4 | Update | 2014/03/03 08:39:26 | Email |
|
| 5 | Update | 2014/03/03 08:40:15 | Recruitment status |
